Central Illustration: Cardiovascular Precision Medicine Integrates Basic Science Techniques With Genomic Information

2019-06-11T07:07:20Z (GMT) by Alexandra M. Dainis Euan A. Ashley
As clinical genome sequencing becomes more common and basic science techniques like CRISPR and induced pluripotent stem cells begin to transition toward clinical applicability, the world of cardiovascular medicine moves toward one where we can be more precise and accurate with our diagnoses and treatment. Using knowledge gained from population sequencing projects, such as genome-wide association studies, and disease models in the laboratory, we can begin to develop deeper understandings of disease at a molecular level to predict the risk of a patient for developing a disease and present them with the right treatment when they do—or the right preventative strategy in advance. This review focuses on how precision medicine, genomics, and new genetic tools intertwine to create a new era of cardiovascular precision medicine. FH = familial hypercholesterolemia; HC = hypertrophic cardiomyopathy; iPSC = induced pluripotent stem cells; LQTS = long QT syndrome.